{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:59:55Z","timestamp":1783720795795,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,8,27]],"date-time":"2011-08-27T00:00:00Z","timestamp":1314403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00417-011-1754-1","type":"journal-article","created":{"date-parts":[[2011,8,26]],"date-time":"2011-08-26T09:27:00Z","timestamp":1314350820000},"page":"95-102","source":"Crossref","is-referenced-by-count":151,"title":["UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study"],"prefix":"10.1007","volume":"250","author":[{"given":"Karim","family":"Makdoumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Sorkhabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Eric","family":"Malmvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Crafoord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,27]]},"reference":[{"key":"1754_CR1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ophtha.2005.08.013","volume":"113","author":"L Keay","year":"2006","unstructured":"Keay L, Edwards K, Naduvilath T, Taylor HR, Snibson GR, Forde K, Stapleton F (2006) Microbial keratitis predisposing factors and morbidity. Ophthalmology 113:109\u2013116","journal-title":"Ophthalmology"},{"key":"1754_CR2","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/bjo.87.7.834","volume":"87","author":"T Bourcier","year":"2003","unstructured":"Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L (2003) Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 87:834\u2013838","journal-title":"Br J Ophthalmol"},{"key":"1754_CR3","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/bjo.87.9.1103","volume":"87","author":"T Wong","year":"2003","unstructured":"Wong T, Ormonde S, Gamble G, McGhee CN (2003) Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol 87:1103\u20131108","journal-title":"Br J Ophthalmol"},{"key":"1754_CR4","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(95)30771-3","volume":"102","author":"SD McLeod","year":"1995","unstructured":"McLeod SD, LaBree LD, Tayyanipour R, Flowers CW, Lee PP, McDonnell PJ (1995) The importance of initial management in the treatment of severe infectious corneal ulcers. Ophthalmology 102:1943\u20131948","journal-title":"Ophthalmology"},{"key":"1754_CR5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1136\/bjo.2008.151167","volume":"93","author":"YW Ibrahim","year":"2009","unstructured":"Ibrahim YW, Boase DL, Cree IA (2009) Epidemiological characteristics, predisposing factors and microbiological profiles of infectious corneal ulcers: the Portsmouth corneal ulcer study. Br J Ophthalmol 93:1319\u20131324","journal-title":"Br J Ophthalmol"},{"key":"1754_CR6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/ICO.0b013e318156caf2","volume":"27","author":"M Green","year":"2008","unstructured":"Green M, Apel A, Stapleton F (2008) Risk factors and causative organisms in microbial keratitis. Cornea 27:22\u201327","journal-title":"Cornea"},{"key":"1754_CR7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/ICO.0b013e3181877a52","volume":"28","author":"A Saeed","year":"2009","unstructured":"Saeed A, D'Arcy F, Stack J, Collum LM, Power W, Beatty S (2009) Risk factors, microbiological findings, and clinical outcomes in cases of microbial keratitis admitted to a tertiary referral center in Ireland. Cornea 28:285\u2013292","journal-title":"Cornea"},{"key":"1754_CR8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1001\/archophthalmol.2010.144","volume":"128","author":"BH Jeng","year":"2010","unstructured":"Jeng BH, Gritz DC, Kumar AB, Holsclaw DS, Porco TC, Smith SD, Whitcher JP, Margolis TP, Wong IG (2010) Epidemiology of ulcerative keratitis in Northern California. Arch Ophthalmol 128:1022\u20131028","journal-title":"Arch Ophthalmol"},{"key":"1754_CR9","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.amjmed.2006.03.014","volume":"119","author":"JE McGowan Jr","year":"2006","unstructured":"McGowan JE Jr (2006) Resistance in nonfermenting Gram-negative bacteria: multidrug resistance to the maximum. Am J Med 119:S29\u2013S36, discussion S62-70","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"1754_CR10","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1086\/504479","volume":"43","author":"AD Harris","year":"2006","unstructured":"Harris AD, McGregor JC, Furuno JP (2006) What infection control interventions should be undertaken to control multidrug-resistant Gram-negative bacteria? Clin Infect Dis 43(Suppl 2):S57\u2013S61","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"1754_CR11","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.3949\/ccjm.74.Suppl_4.S12","volume":"74","author":"LB Rice","year":"2007","unstructured":"Rice LB (2007) Emerging issues in the management of infections caused by multidrug-resistant Gram-negative bacteria. Cleve Clin J Med 74(Suppl 4):S12\u2013S20","journal-title":"Cleve Clin J Med"},{"key":"1754_CR12","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijantimicag.2006.12.012","volume":"29","author":"ME Falagas","year":"2007","unstructured":"Falagas ME, Bliziotis IA (2007) Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era? Int J Antimicrob Agents 29:630\u2013636","journal-title":"Int J Antimicrob Agents"},{"key":"1754_CR13","doi-asserted-by":"crossref","unstructured":"Souli M, Galani I, Giamarellou H (2008) Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe. Euro Surveill 13(47). pii:19045","DOI":"10.2807\/ese.13.47.19045-en"},{"key":"1754_CR14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/OPTH.S5778","volume":"3","author":"JS Bertino","year":"2009","unstructured":"Bertino JS (2009) Impact of antibiotic resistance in the management of ocular infections: the role of current and future antibiotics. Clin Ophthalmol 3:507\u2013521","journal-title":"Clin Ophthalmol"},{"key":"1754_CR15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000219684","volume":"42","author":"G Betanzos-Cabrera","year":"2009","unstructured":"Betanzos-Cabrera G, Juarez-Verdayes MA, Gonzalez-Gonzalez G, Cancino-Diaz ME, Cancino-Diaz JC (2009) Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis. Ophthalmic Res 42:43\u201348","journal-title":"Ophthalmic Res"},{"key":"1754_CR16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/ICO.0b013e318176189e","volume":"27","author":"JC Ramos-Esteban","year":"2008","unstructured":"Ramos-Esteban JC, Bamba S, Jeng BH (2008) Treatment of multidrug-resistant Flavobacterium indologenes keratitis with trimethoprim-sulfamethoxazole. Cornea 27:1074\u20131076","journal-title":"Cornea"},{"key":"1754_CR17","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.jcrs.2007.07.019","volume":"33","author":"M Moshirfar","year":"2007","unstructured":"Moshirfar M, Meyer JJ, Espandar L (2007) Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis. J Cataract Refract Surg 33:1978\u20131981","journal-title":"J Cataract Refract Surg"},{"key":"1754_CR18","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jcrs.2007.03.035","volume":"33","author":"J Cruz de la","year":"2007","unstructured":"de la Cruz J, Behlau I, Pineda R (2007) Atypical mycobacteria keratitis after laser in situ keratomileusis unresponsive to fourth-generation fluoroquinolone therapy. J Cataract Refract Surg 33:1318\u20131321","journal-title":"J Cataract Refract Surg"},{"key":"1754_CR19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/01.icu.0000233954.86723.25","volume":"17","author":"G Wollensak","year":"2006","unstructured":"Wollensak G (2006) Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 17:356\u2013360","journal-title":"Curr Opin Ophthalmol"},{"key":"1754_CR20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ajo.2009.10.021","volume":"149","author":"A Caporossi","year":"2010","unstructured":"Caporossi A, Mazzotta C, Baiocchi S, Caporossi T (2010) Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. Am J Ophthalmol 149:585\u2013593","journal-title":"Am J Ophthalmol"},{"key":"1754_CR21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0002-9394(02)02220-1","volume":"135","author":"G Wollensak","year":"2003","unstructured":"Wollensak G, Spoerl E, Seiler T (2003) Riboflavin\/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 135:620\u2013627","journal-title":"Am J Ophthalmol"},{"key":"1754_CR22","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jcrs.2007.12.039","volume":"34","author":"F Raiskup-Wolf","year":"2008","unstructured":"Raiskup-Wolf F, Hoyer A, Spoerl E, Pillunat LE (2008) Collagen crosslinking with riboflavin and ultraviolet\u2014a light in keratoconus: long-term results. J Cataract Refract Surg 34:796\u2013801","journal-title":"J Cataract Refract Surg"},{"key":"1754_CR23","doi-asserted-by":"crossref","first-page":"S720","DOI":"10.3928\/1081597X-20080901-15","volume":"24","author":"C Wittig-Silva","year":"2008","unstructured":"Wittig-Silva C, Whiting M, Lamoureux E, Lindsay RG, Sullivan LJ, Snibson GR (2008) A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. J Refract Surg 24:S720\u2013S725","journal-title":"J Refract Surg"},{"key":"1754_CR24","unstructured":"Vinciguerra P, Camesasca FI, Albe E, Trazza S (2009) Corneal collagen cross-linking for ectasia after excimer laser refractive surgery: 1-year results. J Refract Surg: 1\u201312"},{"key":"1754_CR25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/112067210601600405","volume":"16","author":"C Mazzotta","year":"2006","unstructured":"Mazzotta C, Traversi C, Baiocchi S, Sergio P, Caporossi T, Caporossi A (2006) Conservative treatment of keratoconus by riboflavin-uva-induced cross-linking of corneal collagen: qualitative investigation. Eur J Ophthalmol 16:530\u2013535","journal-title":"Eur J Ophthalmol"},{"key":"1754_CR26","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/bjo.2009.164228","volume":"94","author":"PT Ashwin","year":"2010","unstructured":"Ashwin PT, McDonnell PJ (2010) Collagen cross-linkage: a comprehensive review and directions for future research. Br J Ophthalmol 94:965\u2013970","journal-title":"Br J Ophthalmol"},{"key":"1754_CR27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2000-10344","volume":"217","author":"E Schnitzler","year":"2000","unstructured":"Schnitzler E, Sporl E, Seiler T (2000) Irradiation of cornea with ultraviolet light and riboflavin administration as a new treatment for erosive corneal processes, preliminary results in four patients. Klin Monbl Augenheilkd 217:190\u2013193","journal-title":"Klin Monbl Augenheilkd"},{"key":"1754_CR28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/ICO.0b013e318169d698","volume":"27","author":"HP Iseli","year":"2008","unstructured":"Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T (2008) Ultraviolet A\/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea 27:590\u2013594","journal-title":"Cornea"},{"key":"1754_CR29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/112067210901900221","volume":"19","author":"T Micelli Ferrari","year":"2009","unstructured":"Micelli Ferrari T, Leozappa M, Lorusso M, Epifani E, Micelli Ferrari L (2009) Escherichia coli keratitis treated with ultraviolet A\/riboflavin corneal cross-linking: a case report. Eur J Ophthalmol 19:295\u2013297","journal-title":"Eur J Ophthalmol"},{"key":"1754_CR30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/ICO.0b013e31819c4e43","volume":"29","author":"H Moren","year":"2010","unstructured":"Moren H, Malmsjo M, Mortensen J, Ohrstrom A (2010) Riboflavin and ultraviolet a collagen crosslinking of the cornea for the treatment of keratitis. Cornea 29:102\u2013104","journal-title":"Cornea"},{"key":"1754_CR31","doi-asserted-by":"crossref","unstructured":"Khan YA, Kashiwabuchi RT, Martins SA, Castro-Combs JM, Kalyani S, Stanley P, Flikier D, Behrens A (2011) Riboflavin and ultraviolet light A therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology 118:324\u2013331","DOI":"10.1016\/j.ophtha.2010.06.041"},{"key":"1754_CR32","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1097\/ICO.0b013e3181d2de91","volume":"29","author":"K Makdoumi","year":"2010","unstructured":"Makdoumi K, Mortensen J, Crafoord S (2010) Infectious keratitis treated with corneal crosslinking. Cornea 29:1353\u20131358","journal-title":"Cornea"},{"key":"1754_CR33","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1167\/iovs.07-1592","volume":"49","author":"SA Martins","year":"2008","unstructured":"Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A (2008) Antimicrobial efficacy of riboflavin\/UVA combination (365\u00a0nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci 49:3402\u20133408","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1754_CR34","doi-asserted-by":"crossref","first-page":"S799","DOI":"10.3928\/1081597X-20090813-07","volume":"25","author":"A Schrier","year":"2009","unstructured":"Schrier A, Greebel G, Attia H, Trokel S, Smith EF (2009) In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. J Refract Surg 25:S799\u2013S802","journal-title":"J Refract Surg"},{"key":"1754_CR35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00417-009-1231-2","volume":"248","author":"K Makdoumi","year":"2010","unstructured":"Makdoumi K, Backman A, Mortensen J, Crafoord S (2010) Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA). Graefes Arch Clin Exp Ophthalmol 248:207\u2013212","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1754_CR36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.transci.2006.01.007","volume":"35","author":"RP Goodrich","year":"2006","unstructured":"Goodrich RP, Edrich RA, Li J, Seghatchian J (2006) The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 35:5\u201317","journal-title":"Transfus Apher Sci"},{"key":"1754_CR37","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1537-2995.2004.03355.x","volume":"44","author":"PH Ruane","year":"2004","unstructured":"Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP (2004) Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion (Paris) 44:877\u2013885","journal-title":"Transfusion (Paris)"},{"key":"1754_CR38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1423-0410.2005.00736.x","volume":"90","author":"LJ Cardo","year":"2006","unstructured":"Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mendez J, Reddy H, Goodrich R (2006) Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang 90:85\u201391","journal-title":"Vox Sang"},{"key":"1754_CR39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.transci.2007.07.002","volume":"37","author":"LJ Cardo","year":"2007","unstructured":"Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R (2007) Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus Apher Sci 37:131\u2013137","journal-title":"Transfus Apher Sci"},{"key":"1754_CR40","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1537-2995.2009.02538.x","volume":"50","author":"L Tonnetti","year":"2010","unstructured":"Tonnetti L, Proctor MC, Reddy HL, Goodrich RP, Leiby DA (2010) Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma. Transfusion (Paris) 50:1019\u20131027","journal-title":"Transfusion (Paris)"},{"key":"1754_CR41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00003226-200401000-00008","volume":"23","author":"G Wollensak","year":"2004","unstructured":"Wollensak G, Spoerl E, Wilsch M, Seiler T (2004) Keratocyte apoptosis after corneal collagen cross-linking using riboflavin\/UVA treatment. Cornea 23:43\u201349","journal-title":"Cornea"},{"key":"1754_CR42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcrs.2005.12.092","volume":"32","author":"M Kohlhaas","year":"2006","unstructured":"Kohlhaas M, Spoerl E, Schilde T, Unger G, Wittig C, Pillunat LE (2006) Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light. J Cataract Refract Surg 32:279\u2013283","journal-title":"J Cataract Refract Surg"},{"key":"1754_CR43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/ICO.0b013e31818225c3","volume":"28","author":"JS Dhaliwal","year":"2009","unstructured":"Dhaliwal JS, Kaufman SC (2009) Corneal collagen cross-linking: a confocal, electron, and light microscopy study of eye bank corneas. Cornea 28:62\u201367","journal-title":"Cornea"},{"key":"1754_CR44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000076150","volume":"218","author":"E Spoerl","year":"2004","unstructured":"Spoerl E, Wollensak G, Dittert DD, Seiler T (2004) Thermomechanical behavior of collagen-cross-linked porcine cornea. Ophthalmologica 218:136\u2013140","journal-title":"Ophthalmologica"},{"key":"1754_CR45","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0886-3350(03)00407-3","volume":"29","author":"G Wollensak","year":"2003","unstructured":"Wollensak G, Spoerl E, Seiler T (2003) Stress-strain measurements of human and porcine corneas after riboflavin-ultraviolet-A-induced cross-linking. J Cataract Refract Surg 29:1780\u20131785","journal-title":"J Cataract Refract Surg"},{"key":"1754_CR46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/02713680490513182","volume":"29","author":"E Spoerl","year":"2004","unstructured":"Spoerl E, Wollensak G, Seiler T (2004) Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res 29:35\u201340","journal-title":"Curr Eye Res"},{"key":"1754_CR47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000151247","volume":"222","author":"F Wang","year":"2008","unstructured":"Wang F (2008) UVA\/riboflavin-induced apoptosis in mouse cornea. Ophthalmologica 222:369\u2013372","journal-title":"Ophthalmologica"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1754-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-011-1754-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1754-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:41:04Z","timestamp":1638405664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-011-1754-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,27]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1754"],"URL":"https:\/\/doi.org\/10.1007\/s00417-011-1754-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,27]]}}}